SSTR2 and neoplasm: Diagnostic imaging with SRS and 68 Ga-DOTATOC PET-CT and immunostaining with SSTR2 provide information on SSTR expression status in the tumor, which combined with an octreotide loading test helps to predict the response to SSA treatment.